Clinical trial
Safety and Immunogenicity of HPV Vaccine in HIV-infected
NCT07797894 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity of HPV Vaccine in HIV-infected
- Lead sponsor
- Beijing 302 Hospital
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- December 30, 2028
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-infected individuals